Co-processed pharmaceutical excipient consisting of two functional excipients: Microcrystalline cellulose and Colloidal silicon dioxide.
MCC Sanaq®S was developed to address the challenges formulators faced with standard Microcrystalline cellulose weakness during direct compression operations, improving the flowability and the compactibility.
MCC Sanaq ®S is the best choice in formulation whereas optimal compaction and optimal flow is required.
MCC Sanaq ®S offer the best balance between flow properties and compaction.
MCC Sanaq® S 102 HD is the choice for obtaining the best disintegration times.
MCC Sanaq® S 102 LM is equivalent to quality of MCC Sanaq S 102, but with lower moisture content ( < 3%)
MCC Sanaq® S flowability differs on the selected grades and it offers favorable flow characteristics suitable for direct compression.
SMCC Sanaq® S exhibits variability in particle size but is generally finer than MCC, contributing to its distinct physical attributes.
